Research On Gene And Radiation Therapy For Prostate Cancer Expanded By Henry Ford Hospital
Feb 7th 2008Drug InformationGenetics
Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment is more effective than radiation therapy alone for patients with intermediate risk prostate cancer.The clinical trial is part of a $9 million grant from the National Cancer Institute (NCI) awarded to Henry Ford to study the effectiveness of gene therapy to treat prostate cancer.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
